Authors: Christodoulou, C Bafaloukos, D Kosmidis, P Samantas, E Bamias, A Papakostas, P Karabelis, A Bacoyiannis, C Skarlos, DV

Citation: C. Christodoulou et al., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases, ANN ONCOL, 12(2), 2001, pp. 249-254

Authors: Tsavaris, N Skarlos, D Bacoyiannis, C Aravantinos, G Kosmas, C Retalis, G Panopoulos, C Vadiaka, M Dimitrakopoulos, A Kostantinidis, K Mitropoulos, D Bougas, D Pantazopoulos, D Kosmidis, P

Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690

Authors: Tsavaris, N Kosmas, C Mylonakis, N Bacoyiannis, C Kalergis, G Vadiaka, M Boulamatsis, D Iakovidis, V Kosmidis, P

Citation: N. Tsavaris et al., Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy, ANTICANC R, 20(6C), 2000, pp. 4777-4783

Authors: Fountzilas, G Stathopoulos, G Nicolaides, C Kalogera-Fountzila, A Kalofonos, H Nikolaou, A Bacoyiannis, C Samantas, E Papadimitriou, C Kosmidis, P Daniilidis, J Pavlidis, N

Citation: G. Fountzilas et al., Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(4), 1999, pp. 475-478